Alexion: Finding Success By Improving Lives

About: Alexion Pharmaceuticals, Inc. (ALXN), Includes: CPRX, GRFS
by: David Zanoni
This article is exclusive for subscribers.
David Zanoni
Momentum, growth at reasonable price, long-term horizon

Alexion develops key treatments for rare disorders, which improves the lives of patients.

Alexion is poised to achieve double-digit increases in revenue and earnings as there is not much competition for the indications that the company addresses.

The reasonable valuation and above-average growth will drive strong stock gains.

When you're feeling like investing with your conscience, a company like Alexion Pharmaceuticals (ALXN) can give you that warm and fuzzy feeling. Alexion develops treatments for rare diseases where no other treatment is